Member Info for chester18

14:00 hours …,.

Once the regulatory requirements are secured and they cover the FDA, EMA and MHRA, a partner will be revealed.

Phil keeps on saying that the partnership will hinge on getting a full understanding of how the trial's design fits with these regulatory bodies.

I would also expect some discussions with the Australian medical authorities. iSCIB1+ could be of great value to the Australians as their melanoma numbers are very high due to miss sold suncreams that were no better than moisturiser.

I thought that the Modi1 update would arrive first but the fact that this partial SCOPE update arrived this morning makes me wonder what the drivers are ?

However Over The Next 2 Days :

Tomorrow at ESMO, Dr Kate Young presenting Scancell Clinical Trial data at 5.15pm, confirmed.

Thursday at ESMO, Prof Heather Shaw presenting iSCIB1+ Data at 11.50am, confirmed.

Thursday at 2.00pm Scancell will Present Up-to-date Data on the SCOPE trial followed by a Q&A Session ( SparkLive ) platform.

Is there still more to reveal or are they clearing the decks for Modi1 data.......

Whichever way you interpret Phil's comments the fact is that iSCIB1+ is progressing towards a ph3 trial.

Unlike most trials, we have very clear insight into the patient population that will see good benefit, which also means the trial will be successfully completed.

With a trial design that will have the most favorable patient conditions built-in how could BMS not want to be an integral part of that success. If they walk away it could cost them future revenues in the £B's.

Not going happen, most likely there will be competition to partner Scancell.

This update is another solid step forward towards the Phase 3 Reg Trial. Incremental steps which that continue to clear the way to a fully approved and highly valued commercial cancer therapy.

Quoth, I think your purchase just before 10.00 am has just turned up ......

Thats a really good number and I hope it turns out to be very well judged 👍👍

Although we haven’t seen that much Scancell interest in terms of daily transactions over recent weeks, I do believe that there are many private investors who are fully aware that trial results are imminent and are ready to buy Scancell on good trial results.

So I’m with Ray on this, the buying we are currently seeing is driven solely by the fact that an RNS is likely and it has a high probability of being positive.

I think a leak of partner news would be pushing the SP well beyond 10.5p and in larger volumes.

With two trials to report on, I think every day going forward has RNS potential, starting with tomorrow 7:00am.

GLA

The important thing to note is that all the millions of shares have been happily picked up by the market and some really large chunks by Vulpes.

Why an Institution is selling is their business and its doesn't seem to have any connection with where Scancell are in the trials or our commercial possibilities.

I expect solid and improved news around iSCIB1+ cohorts 3 and 4.

Plus, fingers well and truly crossed for Modi 1 + Cpi's to be a step change in RCC standard of care and continued positive progress in Head & Neck.

Hearing the news that in the USA they are withdrawing some vaccines from kids let’s remind ourselves that Scancell are aiming to produce Cancer Immunotherapies.

The distinction could be very significant going forward.

The presentation is 5:15pm on Wednesday 10th, getting ahead of myself.

Tuesday is still a good prospect but if not Wednesday would be OK by me 😃

Tuesday does look promising for the first RNS trial update. The presentation at ESMO ( 5:15pm ) by Dr Kate Young is not only her take on iSCIB1+ but backed up by very many clinicians involved with the SCOPE trial. In other words, it’s a ‘proud to present’ huge positive for the progress of the trial and for Scancell by all those who are face to face with the patients.

It’s not guaranteed but an RNS update prior to that presentation would allow for a greater sense of the trials impacts on patient outcomes.

Logged as taking place at :

5:15 pm Wednesday 10th December.

That’s more like it …….

Two extremely well run trials both definitely giving more time to patients who needed a new approach.

Let’s see what tomorrow brings but that large buy sets a very positive tone.

GLA

TF

First time I went to Old Trafford to watch a match was 1975 and it was a revelation. So I probably didn’t see your hero Ron actually play.

I had met the United players in 1970 when I had a visit to the Cliff ( training ground ) with my dad. Watched in complete awe as George Best dazzled his own team mates. Most memorable moments were Dennis Law roughing up my hair and saying ‘you alright kid’ and Sir Matt asking if I thought I was a good enough player. He said if I ever wanted to go for a trial, I could, and if anybody asked to tell them he said it was ok.

I never did but just to be told was good enough for me. He was obviously a great believer in bringing the youngsters through and you never know where the next Bobby, Dennis or Georgie was going to come from.

Great memories and as any football fan knows once you are smitten by a team it’s for life …… 👊👊

Nope …. a Man Utd fan that dreads the thought of another game against 10 men .

Against 11 we have a fair chance 🫣

Obviously someone or some institution has to sell down their holding but it seems crazy this close to the trial updates.

Nothing is every straight forward or easy is it ?

Saw those two trades go through as buys on Monday circa 0.1050p and sold today. Nice bit of solid ramping and a Friday pay day….. it’s done so cynically …..

Hopefully there is a morsel of truth in the Han(ock story.

I’m just hoping Crystal Palace don’t have a player sent off ……. 🤦

👍👍

Thanks Drb83

Hopefully with Silver back above $50 the SP will react positively to those assays when they land.

I'm especially keen to see how the Australian Market reacts as when WCE stock rises UFO usually follows.

GLA

When are the first 3 / 5 driil cores due back from the lab ?